Except for three subsets of tumor infiltrated immune cells including Gamma delta T cell, CD56 bright natural killer cell, and CD56 dim natural killer cell, the other 25 out of 28 subsets of tumor infiltrated immune cells showed a dramatic decrease in high-risk group as compared to low-risk group (Fig. 6A). This evidence concerns the gene NCAM1 and neoplasm.